| scholarly article | Q13442814 |
| P2093 | author name string | Shelley A Tischkau | |
| Sumedha W Karmarkar | |||
| P2860 | cites work | Molecular cloning of human p38 MAP kinase | Q72109756 |
| Differential cAMP gating of glutamatergic signaling regulates long-term state changes in the suprachiasmatic circadian clock | Q73066564 | ||
| Circadian variations of ischemic burden among patients with myocardial infarction undergoing primary percutaneous coronary intervention | Q83392557 | ||
| Time and concentration dependency of the toxicity of excitatory amino acids on cerebral neurones in primary culture | Q84298295 | ||
| Clock genes in calendar cells as the basis of annual timekeeping in mammals--a unifying hypothesis | Q22305881 | ||
| Obesity and metabolic syndrome in circadian Clock mutant mice | Q24627935 | ||
| Disruption of the clock components CLOCK and BMAL1 leads to hypoinsulinaemia and diabetes | Q24633002 | ||
| Circadian clock-deficient mice as a tool for exploring disease etiology | Q26995743 | ||
| Stability, precision, and near-24-hour period of the human circadian pacemaker | Q28138096 | ||
| High-fat diet-induced hyperinsulinemia and tissue-specific insulin resistance in Cry-deficient mice | Q28511606 | ||
| Requirement of Mammalian Timeless for Circadian Rhythmicity | Q28566744 | ||
| Disruption of CLOCK-BMAL1 transcriptional activity is responsible for aryl hydrocarbon receptor-mediated regulation of Period1 gene | Q29347268 | ||
| Differential activation of ERK and JNK mitogen-activated protein kinases by Raf-1 and MEKK | Q29620274 | ||
| NMDA as well as non-NMDA receptor antagonists can prevent the phase-shifting effects of light on the circadian system of the golden hamster | Q30437822 | ||
| Cellular mechanisms of entrainment | Q30437839 | ||
| Vascular disease in mice with a dysfunctional circadian clock | Q30490924 | ||
| Influence of circadian rhythm on mortality after myocardial infarction: data from a prospective cohort of emergency calls | Q30981168 | ||
| Healthy clocks, healthy body, healthy mind | Q33598574 | ||
| Disrupting circadian homeostasis of sympathetic signaling promotes tumor development in mice | Q33601559 | ||
| Circadian clocks and vascular function | Q33765425 | ||
| Circadian regulation of a Drosophila homolog of the mammalian Clock gene: PER and TIM function as positive regulators | Q33781149 | ||
| ERK/MAPK is essential for endogenous neuroprotection in SCN2.2 cells | Q33999730 | ||
| Individual neurons dissociated from rat suprachiasmatic nucleus express independently phased circadian firing rhythms | Q34058703 | ||
| Cardiovascular chronobiology: do you know what time it is? | Q34259397 | ||
| The mammalian circadian clock shop. | Q34313576 | ||
| Circadian clocks in prokaryotes | Q34400771 | ||
| The role of glutamate in the photic regulation of the suprachiasmatic nucleus | Q34411465 | ||
| Neurotransmitters of the retino-hypothalamic tract | Q34732744 | ||
| Circadian rhythm disorganization produces profound cardiovascular and renal disease in hamsters | Q34749905 | ||
| Genetics and neurobiology of circadian clocks in mammals | Q34770761 | ||
| Chronopharmacology of cardiovascular therapy | Q34799816 | ||
| Apoptosis pathways in cancer and cancer therapy | Q35642088 | ||
| Circadian dependence of infarct size and left ventricular function after ST elevation myocardial infarction | Q35659244 | ||
| Aryl hydrocarbon receptor deficiency enhances insulin sensitivity and reduces PPAR-α pathway activity in mice | Q35682887 | ||
| Circadian variations in blood pressure : implications for chronotherapeutics | Q35999525 | ||
| Oligodeoxynucleotide methods for analyzing the circadian clock in the suprachiasmatic nucleus | Q36091938 | ||
| Circadian variation in stroke onset: identical temporal pattern in ischemic and hemorrhagic events | Q36217117 | ||
| Impact of shift work on the health and safety of nurses and patients | Q36574856 | ||
| Circadian patterns of gene expression in the human brain and disruption in major depressive disorder | Q36932183 | ||
| Calbindin d28k overexpression protects striatal neurons from transient focal cerebral ischemia | Q46132048 | ||
| The luteinizing hormone surge regulates circadian clock gene expression in the chicken ovary | Q46637759 | ||
| Oscillation and light induction of timeless mRNA in the mammalian circadian clock | Q48188417 | ||
| Activation of NMDA receptors in the suprachiasmatic nucleus produces light-like phase shifts of the circadian clock in vivo | Q48188473 | ||
| Disturbed diurnal rhythm alters gene expression and exacerbates cardiovascular disease with rescue by resynchronization | Q48252381 | ||
| Analysis of sleep-wakefulness rhythms in male rats after suprachiasmatic nucleus lesions and ocular enucleation | Q48314208 | ||
| Optic nerve stimulation-induced increase of release of 3H-glutamate and 3H-aspartate but not 3H-GABA from the suprachiasmatic nucleus in slices of rat hypothalamus | Q48363791 | ||
| Early morning surge and dipping status of blood pressure: are these of predictive value for silent myocardial ischemia? | Q48395286 | ||
| Pretreatment with PTD-calbindin D 28k alleviates rat brain injury induced by ischemia and reperfusion | Q48462656 | ||
| Age-related change in the relationship between circadian period, circadian phase, and diurnal preference in humans | Q48672816 | ||
| Chronobiology of aging: temperature, sleep-wake rhythms and entrainment | Q49151053 | ||
| Circadian clock gene expression in the ovary: Effects of luteinizing hormone. | Q51171237 | ||
| Time-of-day affects expression of hippocampal markers for ischemic damage induced by global ischemia. | Q53521923 | ||
| [Brain stem potentials evoked by electric stimulation of the auditory nerve] | Q70218031 | ||
| Resetting the biological clock: mediation of nocturnal circadian shifts by glutamate and NO | Q71661849 | ||
| Clinical assessment of early morning blood pressure in patients with hypertension | Q36961407 | ||
| Mitogen-activated protein kinase kinase 1/2 inhibitors and 17-allylamino-17-demethoxygeldanamycin synergize to kill human gastrointestinal tumor cells in vitro via suppression of c-FLIP-s levels and activation of CD95. | Q36979035 | ||
| The impact of the circadian timing system on cardiovascular and metabolic function | Q36991496 | ||
| The morning blood pressure surge: therapeutic implications | Q37079675 | ||
| RETRACTED: GCK is essential to systemic inflammation and pattern recognition receptor signaling to JNK and p38 | Q37132899 | ||
| Prokineticin-signaling pathway | Q37149093 | ||
| p38 MAP kinase inhibition promotes primary tumour growth via VEGF independent mechanism | Q37448644 | ||
| Circadian clock genes and sleep homeostasis. | Q37497516 | ||
| The cortisol awakening response: more than a measure of HPA axis function. | Q37660680 | ||
| Chronotherapeutic strategy: Rhythm monitoring, manipulation and disruption | Q37699669 | ||
| A timely review of state-of-the-art chronopharmaceuticals synchronized with biological rhythms | Q37800502 | ||
| New perspectives in melatonin uses | Q37981946 | ||
| Nocturnal blood pressure and cardiovascular disease: a review of recent advances | Q37989406 | ||
| Clock genes and clock-controlled genes in the regulation of metabolic rhythms | Q37990529 | ||
| Nocturnal blood pressure, morning blood pressure surge, and cerebrovascular events | Q38005055 | ||
| The circadian output signals from the suprachiasmatic nuclei | Q38033285 | ||
| Dipper and non-dipper blood pressure 24-hour patterns: circadian rhythm-dependent physiologic and pathophysiologic mechanisms. | Q38045905 | ||
| Shift work and cancer risk: potential mechanistic roles of circadian disruption, light at night, and sleep deprivation | Q38058576 | ||
| Peripheral circadian oscillators in mammals | Q38100624 | ||
| Chronotherapy improves blood pressure control and reduces vascular risk in CKD. | Q38100986 | ||
| Sleep and circadian rhythm disruption in neuropsychiatric illness. | Q38101733 | ||
| Melatonin: comprehensive profile | Q38106279 | ||
| Suprachiasmatic nuclei Lessions in the rat: Alterations in sleep circadian rhythms | Q39500878 | ||
| Suprachiasmatic nucleus neurons display endogenous resistance to excitotoxicity | Q39713141 | ||
| Ambulatory versus casual blood pressure in the diagnosis of hypertensive patients | Q39822261 | ||
| Cerebral consequences of acute and chronic hypertension: an overview | Q39842329 | ||
| The molecular mechanisms of neuronal apoptosis | Q40588445 | ||
| Oxidative stress, glutamate, and neurodegenerative disorders | Q40618533 | ||
| Apoptosis: the physiologic pathway of cell death | Q40618987 | ||
| Real-time analysis of rhythmic gene expression in immortalized suprachiasmatic nucleus cells | Q40689010 | ||
| Two different families of NMDA receptors in mammalian brain: physiological function and role in neuronal development and degeneration. | Q40718808 | ||
| Organization of the primate circadian system. | Q40797621 | ||
| Glutamate receptors and excitotoxicity. | Q40850700 | ||
| Establishment and characterization of adenoviral E1A immortalized cell lines derived from the rat suprachiasmatic nucleus | Q40958957 | ||
| Light, immediate-early genes, and circadian rhythms | Q41074257 | ||
| Circadian disruption leads to insulin resistance and obesity | Q41224916 | ||
| Ischemia-induced neuronal apoptosis | Q41235586 | ||
| Biological rhythms in the human life cycle and their relationship to functional changes in the suprachiasmatic nucleus | Q41304811 | ||
| Neonatal suprachiasmatic nucleus lesions: Effects on the development of circadian rhythms in the rat | Q41485439 | ||
| The circadian pattern of blood pressure: cardiovascular risk and therapeutic opportunities | Q41571059 | ||
| Morphological characterization of immortalized hypothalamic neurons synthesizing luteinizing hormone-releasing hormone | Q41666731 | ||
| Temporal regulation of light-induced extracellular signal-regulated kinase activation in the suprachiasmatic nucleus | Q42446438 | ||
| Differences in activation of ERK1/2 and p38 kinase in Jnk3 null mice following KA treatment. | Q43037982 | ||
| Rapid subcellular redistribution of Bax precedes caspase-3 and endonuclease activation during excitotoxic neuronal apoptosis in rat brain | Q44107197 | ||
| 2013 ambulatory blood pressure monitoring recommendations for the diagnosis of adult hypertension, assessment of cardiovascular and other hypertension-associated risk, and attainment of therapeutic goals | Q44360459 | ||
| Effects of chronic jet lag on tumor progression in mice. | Q45134031 | ||
| P921 | main subject | circadian rhythm | Q208353 |
| excitotoxicity | Q901117 | ||
| P304 | page(s) | 313 | |
| P577 | publication date | 2013-11-05 | |
| P1433 | published in | Frontiers in Physiology | Q2434141 |
| P1476 | title | Influences of the circadian clock on neuronal susceptibility to excitotoxicity | |
| P478 | volume | 4 |
| Q90442755 | Circadian regulation of astrocyte function: implications for Alzheimer's disease |
| Q27011441 | Deregulation of the circadian clock constitutes a significant factor in tumorigenesis: a clockwork cancer. Part II. In vivo studies |
| Q30369597 | Identification of a Circadian Clock in the Inferior Colliculus and Its Dysregulation by Noise Exposure |
| Q96131831 | Potential circadian effects on translational failure for neuroprotection |
| Q38410871 | Researching glutamate - induced cytotoxicity in different cell lines: a comparative/collective analysis/study |
| Q93004712 | Sleep and clocks - implications for brain health |
Search more.